MyFinsight
Home
Blog
About
Contact
Download
Download image
Revenues
$610,812K
(9.97%↑ Y/Y)
Interest income
$16,127K
(-15.46%↓ Y/Y)
Net income
$210,467K
(31.86%↑ Y/Y)
Prepaid expenses and
other assets
-$58,653K
(-188.65%↓ Y/Y)
Canceled cashflow
$416,472K
Stock-based compensation
$29,050K
(12.03%↑ Y/Y)
Depreciation and
amortization
$6,948K
(-5.41%↓ Y/Y)
Non-cash lease expense
$5,994K
(-1.67%↓ Y/Y)
Accrued collaboration
liabilities
$4,044K
(-12.18%↓ Y/Y)
Acquired in-process
research and development...
$2,025K
(-89.62%↓ Y/Y)
Net cash provided by
operating activities
$251,845K
(19.11%↑ Y/Y)
Canceled cashflow
$65,336K
Development
$135,715K
(-11.42%↓ Y/Y)
Selling, general, and
administrative
$122,870K
(1.73%↑ Y/Y)
Other segment items
$61,238K
(6.66%↑ Y/Y)
Provision for income taxes
$57,220K
(24.19%↑ Y/Y)
Cost of goods sold
$19,953K
(4.07%↑ Y/Y)
Drug discovery
$19,476K
(6.70%↑ Y/Y)
Net decrease in cash
and cash...
-$256,336K
(-662.41%↓ Y/Y)
Canceled cashflow
$251,845K
Proceeds from issuance of
common stock under the...
$7,472K
(-35.74%↓ Y/Y)
Proceeds from maturities
and sales of...
$225,125K
(-13.05%↓ Y/Y)
Trade receivables,
net
$42,031K
(160.75%↑ Y/Y)
Accounts payable and
other liabilities
-$17,897K
(-310.53%↓ Y/Y)
Inventory
$3,389K
(4673.24%↑ Y/Y)
Other, net
$2,019K
(-57.81%↓ Y/Y)
Net cash used in
financing activities
-$457,111K
(-55.05%↓ Y/Y)
Canceled cashflow
$7,472K
Net cash provided by
(used in) investing...
-$51,070K
(-202.62%↓ Y/Y)
Canceled cashflow
$225,125K
Payments for repurchases
of common stock
$430,352K
(51.57%↑ Y/Y)
Taxes paid related to
net share...
$34,231K
(52.03%↑ Y/Y)
Purchases of marketable
securities
$274,161K
(46.84%↑ Y/Y)
Purchases of property,
equipment and other, net
$1,509K
(-48.88%↓ Y/Y)
Acquired in-process
research and development...
$525K
(-97.31%↓ Y/Y)
Back
Back
Cash Flow
Exelixis-Logo-2023-svg
EXELIXIS, INC. (EXEL)
Exelixis-Logo-2023-svg
EXELIXIS, INC. (EXEL)
source: myfinsight.com